Clemens J von Bühler

Cluster Screening: An Effective Approach for Probing the Substrate Space of Uncharacterized Cytochrome P450s

V. Urlacher, Clemens J von Bühler, Priska Le‐Huu, 2013, Chembiochem : a European journal of chemical biology.

Metabolism and Mass Balance of the Novel Nonsteroidal Androgen Receptor Inhibitor Darolutamide in Humans

M. Kähkönen, M. Koskinen, T. Korjamo, 2021, Drug Metabolism and Disposition.

Whole-cell biotransformation with recombinant cytochrome P450 for the selective oxidation of Grundmann's ketone.

V. Urlacher, S. Fernández, Clemens J von Bühler, 2014, Bioorganic & medicinal chemistry.

A Potent and Selective Human Prostaglandin F (FP) Receptor Antagonist (BAY-6672) for the Treatment of Idiopathic Pulmonary Fibrosis (IPF).

Michaela Bairlein, Timo Stellfeld, L. Dietz, 2020, Journal of medicinal chemistry.

Drug–Drug Interaction Potential of Darolutamide: In Vitro and Clinical Studies

Michaela Bairlein, M. Koskinen, T. Korjamo, 2019, European Journal of Drug Metabolism and Pharmacokinetics.

Selective allylic hydroxylation of acyclic terpenoids by CYP154E1 from Thermobifida fusca YX

S. Laschat, V. Urlacher, Alexander Seifert, 2014, Beilstein journal of organic chemistry.

A novel cytochrome P450 mono‐oxygenase from Streptomyces platensis resembles activities of human drug metabolizing P450s

V. Urlacher, A. Vogel, S. Lütz, 2018, Biotechnology and bioengineering.

A novel P450-based biocatalyst for the selective production of chiral 2-alkanols.

V. Urlacher, Clemens J von Bühler, 2014, Chemical Communications.

A novel P450-based biocatalyst for the selective production of chiral 2-alkanols.

V. Urlacher, Clemens J von Bühler, 2014, Chemical communications.